Biren K. Joshi

Antifungal Metabolites (Monorden, Monocillin IV, and Cerebrosides) from <i>Humicola fuscoatra</i> Traaen NRRL 22980, a Mycoparasite of <i>Aspergillus flavus</i> Sclerotia

Donald T. Wicklow, Biren K. Joshi, William R. Gamble et al. · Applied and Environmental Microbiology · 1998 · 94 citations · Full text

Sclerotigenin:  A New Antiinsectan Benzodiazepine from the Sclerotia of <i>Penicillium sclerotigenum</i>

Biren K. Joshi, James B. Gloer, Donald T. Wicklow et al. · Journal of Natural Products · 1999 · 73 citations

Molecular Pharmacology, Medicinal Chemistry, New Antiinsectan Benzodiazepine +10

Phosphine-Catalyzed Annulation of Thioamides and 2-Alkynoates:  A New Synthesis of Thiazolines

Bing Liu, Roman Davis, Biren K. Joshi et al. · The Journal of Organic Chemistry · 2002 · 73 citations

2-Aryl Substituents, Heterocyclic, Phosphine-catalyzed Annulation +9

Bioactive Natural Products from a Sclerotium-Colonizing Isolate of <i>Humicola fuscoatra</i>

Biren K. Joshi, James B. Gloer, Donald T. Wicklow · Journal of Natural Products · 2002 · 50 citations

Antifungal Agent, Engineering, Biochemistry +13

Recent Trends in Product Development and Regulatory Issues on Impurities in Active Pharmaceutical Ingredient (API) and Drug Products. Part 1: Predicting Degradation Related Impurities and Impurity Considerations for Pharmaceutical Dosage Forms

Karen M. Alsante, Kim Huynh‐Ba, Steven W. Baertschi et al. · AAPS PharmSciTech · 2013 · 32 citations · Full text

Chemical Engineering, Part 1, Active Ingredient +9